BlackRock ESG Capital Allocation Term Trust Defends Board Against Activist Saba Capital in Proxy Battle
ECAT sits 15% above its 52-week low of $13.36.
Summary
BlackRock ESG Capital Allocation Term Trust (ECAT) has filed additional proxy materials, urging shareholders to support its current board and reject activist Saba Capital Management's nominees.
Key Events · Corporate Governance and Compliance · ECAT
-
Board Defense in Proxy Battle
ECAT's independent Board is actively campaigning to retain its current members, arguing that 'Change is NOT warranted' amidst the ongoing proxy contest with Saba Capital Management. This follows multiple proxy filings from both sides since February 2026.
-
Highlights Superior Performance
The filing emphasizes ECAT's 'superior shareholder returns,' 'higher yield on net asset value,' 'narrower discount,' and 'lower expense ratio' compared to its peers, presenting data up to April 30, 2026.
-
Accuses Activist of Selling Shares
ECAT explicitly states that Saba Capital Management has been 'aggressively selling ECAT' shares, representing a meaningful share of trading volume, while simultaneously seeking to take over the Board.
-
Details Board Qualifications and Governance
The company outlines the comprehensive skills and independence of its current board members and details rigorous governance and oversight practices, including discount management programs and shareholder engagement.
Analysis · ECAT · Unknown
This filing is a critical communication from BlackRock ESG Capital Allocation Term Trust (ECAT) to shareholders, part of an intense and ongoing proxy battle with activist investor Saba Capital Management. The company is actively soliciting votes to retain its current board, presenting arguments and performance data to counter Saba's nominations. The outcome of this board election will significantly impact the fund's future governance and strategy.
At the time of this filing, ECAT was trading at $15.39 on NYSE in the Unknown sector. The 52-week trading range was $13.36 to $17.14. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.